scispace - formally typeset
R

Ruchi Tiwari

Researcher at Pranveer Singh Institute of Technology

Publications -  315
Citations -  15581

Ruchi Tiwari is an academic researcher from Pranveer Singh Institute of Technology. The author has contributed to research in topics: Medicine & Coronavirus. The author has an hindex of 50, co-authored 289 publications receiving 10401 citations. Previous affiliations of Ruchi Tiwari include Indian Council of Agricultural Research & Indian Institute of Technology Delhi.

Papers
More filters
Journal Article

Escherichia coli, an economically important avian pathogen, its disease manifestations, diagnosis and control, and public health significance: a review.

Kuldeep Dhama, +5 more
- 01 Jan 2013 - 
TL;DR: Different disease manifestations caused by APEC, insights into this economically important avian pathogen, epidemiology, trends and advances in diagnosis, prevention and control, novel and emerging therapeutic regimens, and the associated public health concerns envisage the topic of discussion in the present review.
Journal ArticleDOI

Formulation and evaluation of the topical ethosomal gel of melatonin to prevent UV radiation

Richa Shukla, +3 more
- 01 Aug 2020 - 
TL;DR: Ethosomes are able to permeate intact through the human skin due to its high deformability, and have variable oral absorption and extensive first‐pass effect.
Journal ArticleDOI

Evolutionary and codon usage preference insights into spike glycoprotein of SARS-CoV-2.

Yashpal Singh Malik, +10 more
- 22 Mar 2021 - 
TL;DR: In this paper, a comprehensive analysis of codon usage bias (CUB) in SARS-CoV-2 revealed significant CUB among the S-genes of different beta-coronaviruses governed majorly by natural selection and mutation pressure.
Journal ArticleDOI

Studies on development of controlled delivery of combination drug(s) to periodontal pocket

Gaurav Tiwari, +2 more
- 01 Jan 2010 - 
TL;DR: Formulations containing HEC exhibited superior physical characteristics for improved drug delivery to the periodontal pocket and are now the subject of long-term clinical investigations.
Journal ArticleDOI

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update

Ranjan K. Mohapatra, +9 more
- 20 May 2022 - 
TL;DR: Current evidence reveals the importance of incorporating booster vaccination using several vaccine platforms, such as viral vector- and mRNA-based vaccines, as well as other platforms that are under explorative investigations, to assess the effectiveness and durability of protection provided by booster COVID-19 vaccination against Omicron and other SARS-CoV-2 variants.